B

Bio-FD&C Co Ltd
KOSDAQ:251120

Watchlist Manager
Bio-FD&C Co Ltd
KOSDAQ:251120
Watchlist
Price: 13 800 KRW -0.14%
Market Cap: 117.7B KRW
Have any thoughts about
Bio-FD&C Co Ltd?
Write Note

Bio-FD&C Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bio-FD&C Co Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
068270
302440
H
145020
P
214450
196170

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Bio-FD&C Co Ltd
KOSDAQ:251120
Cash & Cash Equivalents
â‚©11.9B
CAGR 3-Years
59%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Cash & Cash Equivalents
â‚©564.6B
CAGR 3-Years
-11%
CAGR 5-Years
5%
CAGR 10-Years
30%
SK Bioscience Co Ltd
KRX:302440
Cash & Cash Equivalents
â‚©127B
CAGR 3-Years
72%
CAGR 5-Years
95%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Cash & Cash Equivalents
â‚©151.6B
CAGR 3-Years
21%
CAGR 5-Years
25%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cash & Cash Equivalents
â‚©78.4B
CAGR 3-Years
51%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Cash & Cash Equivalents
â‚©37.8B
CAGR 3-Years
48%
CAGR 5-Years
45%
CAGR 10-Years
N/A

See Also

What is Bio-FD&C Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
11.9B KRW

Based on the financial report for Dec 31, 2023, Bio-FD&C Co Ltd's Cash & Cash Equivalents amounts to 11.9B KRW.

What is Bio-FD&C Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
40%

Over the last year, the Cash & Cash Equivalents growth was 4%. The average annual Cash & Cash Equivalents growth rates for Bio-FD&C Co Ltd have been 59% over the past three years , 40% over the past five years .

Back to Top